These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12023428)

  • 1. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.
    Winnock M; Letenneur L; Jacqmin-Gadda H; Dallongeville J; Amouyel P; Dartigues JF
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):794-7. PubMed ID: 12023428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
    JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
    Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
    Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
    Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Function of Delayed Recall in Non-demented Elderly Subjects With Apolipoprotein E ε4 Allele.
    Wang L; Pan X; Fei G; Wang C; Wan W; Sang S; Wang H; Wang Z; Zhong C
    Front Aging Neurosci; 2019; 11():71. PubMed ID: 30983990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
    Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
    Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of apolipoprotein E and cognitive function in old age.
    Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
    Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.
    Kaup AR; Nettiksimmons J; Harris TB; Sink KM; Satterfield S; Metti AL; Ayonayon HN; Yaffe K;
    JAMA Neurol; 2015 Mar; 72(3):340-8. PubMed ID: 25599330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
    Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
    Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers.
    Dufouil C; Tzourio C; Brayne C; Berr C; Amouyel P; Alpérovitch A
    Epidemiology; 2000 May; 11(3):280-4. PubMed ID: 10784244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
    Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG; Brayne C; Easton D; Rubinsztein DC;
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.